Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit

Critical Care Medicine

Volumn 37, Issue 8, 2009, Pages 2350-2358

  Kalil, Andre C ^a   Florescu, Diana F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus; Intensive care unit; Nonimmuno compromised

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; COHORT ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEROLOGY; SYSTEMATIC REVIEW; VIRUS CULTURE;

EID: 68249116041     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a3aa43     Document Type: Article

References (40)

1. Stanberry LR, Rosenthal SL, Mills L, et al: Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis 2004; 39:1433-1438
2. Gandhi MK, Khanna R: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 2004; 4:725-738
3. Kalil AC, Levitsky J, Lyden E, et al: Metaanalysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005; 143:870-880
4. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128
5. Cook CH, Trgovcich J, Zimmerman PD, et al: Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 2006; 80:9151-9158
6. Domart Y, Trouillet JL, Fagon JY, et al: Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 1990; 97:18-22
7. Papazian L, Fraisse A, Garbe L, et al: Cytomegalovirus: an unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280-287
8. Stephan F, Meharzi D, Ricci S, et al: Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation. Intensive Care Med 1996; 22:1244-1249
9. Kutza AS, Muhl E, Hackstein H, et al: High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998; 26:1076-1082
10. Cook CH, Yenchar JK, Kraner TO, et al: Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998; 176:357-360
11. Desachy A, Ranger-Rogez S, Francois B, et al: Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 2001; 32:197-203
12. Heininger A, Jahn G, Engel C, et al: Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541-547
13. Razonable RR, Fanning C, Brown RA, et al: Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis 2002; 185: 110-113
14. Cook CH, Martin LC, Yenchar JK, et al: Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003; 31:1923-1929
15. Jaber S, Chanques G, Borry J, et al: Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005; 127:233-241
16. von Muller L, Klemm A, Weiss M, et al: Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 2006; 12: 1517-1522
17. Limaye AP, Kirby KA, Rubenfeld GD, et al: Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300:413-422
18. Ziemann M, Sedemund-Adib B, Reiland P, et al: Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008; 36:3145-3150
19. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
20. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
21. Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560
22. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement: quality of reporting of meta-analyses. Lancet 1999; 354:1896-1900
23. Stroup DF, Berlin JA, Morton SC, et al: Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012
24. Sterne JA, Gavaghan D, Egger M: Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000; 53:1119-1129
25. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
26. Abraham E, Reinhart K, Opal S, et al: Effi-cacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290:238-247
27. Warren BL, Eid A, Singer P, et al: Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286:1869-1878
28. Reeves M, Sinclair J: Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 2008; 325:297-313
29. Cook CH, Zhang Y, McGuinness BJ, et al: Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 2002; 185:1395-1400
30. Soderberg-Naucler C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91:119-126
31. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al: Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008; 5:47
32. Levitsky J, Freifeld AG, Puumala S, et al: Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes? Clin Transplant 2008; 22:222-228
33. Ho M: Cytomegalovirus infection in patients with bacterial sepsis. Clin Infect Dis 1998; 26:1083-1084
34. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
35. Docke WD, Prosch S, Fietze E, et al: Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343:268-269
36. Prosch S, Wendt CE, Reinke P, et al: A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 2000; 272:357-365
37. Andrews DM, Andoniou CE, Granucci F, et al: Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001; 2:1077-1084
38. Bruggeman CA, Debie WH, Muller AD, et al: Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost 1988; 59:264-268
39. Sutherland MR, Raynor CM, Leenknegt H, et al: Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A 1997; 94:13510-13514
40. Marik PE, Corwin HL: Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36:2667-2674